Literature DB >> 25821232

Morphological distribution of lung cancer from Cancer Incidence in Five Continents Vol. X.

Tomohiro Matsuda1, Ryoko Machii2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25821232     DOI： 10.1093/jjco/hyv041

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  19 in total

1.  Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.

Authors:  Ting-Qing Gan; Wen-Jie Chen; Hui Qin; Su-Ning Huang; Li-Hua Yang; Ye-Ying Fang; Lin-Jiang Pan; Zu-Yun Li; Gang Chen
Journal:  Med Sci Monit       Date:  2017-05-23

2.  High O-linked N-acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma.

Authors:  Yi-Cheng Lin; Chia-Hung Lin; Yi-Chen Yeh; Hsiang-Ling Ho; Yu-Chung Wu; Mei-Yu Chen; Teh-Ying Chou
Journal:  Oncotarget       Date:  2018-07-24

3.  Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.

Authors:  Yi Wan; Xin Wang; Ting Liu; Tianyu Fan; Zugui Zhang; Bin Wang; Bei Zhang; Zibin Tian; Tao Mao; Zheng Gong; Li Zhang
Journal:  Cancer Med       Date:  2021-05-04       Impact factor: 4.452

4.  Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.

Authors:  Hong Shen; Ying Cao; Xiaofen Li; Yinuo Tan; Jiaqi Chen; Ziru Yang; Yiyao Kong; Ying Yuan
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 5.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

Review 6.  MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.

Authors:  Irina Fadejeva; Horst Olschewski; Andelko Hrzenjak
Journal:  Oncotarget       Date:  2017-12-05

7.  DRG1 is a potential oncogene in lung adenocarcinoma and promotes tumor progression via spindle checkpoint signaling regulation.

Authors:  Li Lu; Yanrong Lv; Ji Dong; Shaohua Hu; Ruiyun Peng
Journal:  Oncotarget       Date:  2016-11-08

Review 8.  Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non-Small Cell Lung Cancer.

Authors:  Jennifer Jacky; Christina Baik
Journal:  J Adv Pract Oncol       Date:  2017-11-01

9.  Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome.

Authors:  Shidan Wang; Alyssa Chen; Lin Yang; Ling Cai; Yang Xie; Junya Fujimoto; Adi Gazdar; Guanghua Xiao
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

10.  Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes.

Authors:  Katherine Sellers; Thaddeus D Allen; Michael Bousamra; JinLian Tan; Andrés Méndez-Lucas; Wei Lin; Nourdine Bah; Yelena Chernyavskaya; James I MacRae; Richard M Higashi; Andrew N Lane; Teresa W-M Fan; Mariia O Yuneva
Journal:  Br J Cancer       Date:  2019-05-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.